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ABSTRACT
Numerous genomic studies are underway to deter-
mine which genes are abnormally regulated by DNA
methylation in disease. However, we have a poor
understanding of how disease-specific methylation
changes affect expression. We thus developed an in-
tegrative analysis tool, Methylation-based Gene Ex-
pression Classification (ME-Class), to explain spe-
cific variation in methylation that associates with
expression change. This model captures the com-
plexity of methylation changes around a gene pro-
moter. Using 17 whole-genome bisulfite sequenc-
ing and RNA-seq datasets from different tissues
from the Roadmap Epigenomics Project, ME-Class
significantly outperforms standard methods using
methylation to predict differential gene expression
change. To demonstrate its utility, we used ME-Class
to analyze 32 datasets from different hematopoietic
cell types from the Blueprint Epigenome project.
Expression-associated methylation changes were
predominantly found when comparing cells from dis-
tantly related lineages, implying that changes in the
cell’s transcriptional program precede associated
methylation changes. Training ME-Class on normal-
tumor pairs from The Cancer Genome Atlas indicated
that cancer-specific expression-associated methy-
lation changes differ from tissue-specific changes.
We further show that ME-Class can detect function-
ally relevant cancer-specific, expression-associated
methylation changes that are reversed upon the re-
moval of methylation. ME-Class is thus a powerful
tool to identify genes that are dysregulated by DNA
methylation in disease.
INTRODUCTION
Establishment of specific patterns of DNA methylation at
CG dinucleotides (CpGs) is necessary for normal devel-
opment (1,2), and aberrant methylation is frequently ob-
served in cancer (3,4). CpG rich-regions, often called CpG
islands (CGIs), are typically unmethylated and associated
with ∼70% of mammalian gene promoters (5). Hyperme-
thylation of CpG islands overlapping the transcription start
site (TSS) is hypothesized to downregulate tumor suppres-
sor genes, thus promoting tumorigenesis (6,7). Typically,
promoters are labeled as either methylated and silenced or
unmethylated and potentially active based on the methyla-
tion levels near the transcription start site (TSS) (8,9). How-
ever, studies that rely upon this simple binary characteriza-
tion (10) to correlate methylation with expression find only
modest negative correlations with expression levels (11–13).
The most common approach to associate DNAmethyla-
tion and expression change is to first identify differentially
methylated regions (DMRs) and then associate them with
nearby genes. Numerous statistical tools have been devel-
oped to identify DMRs (10). Generally, DMRs are found
by segmenting the genome into equally spaced regions and
identifyingwhich regions have statistically significant differ-
ences in methylation. DMRs are then associated with genes
or other genomic regulatory elements within a certain dis-
tance to gain biological insight into their potential func-
tion. While DMR-based methods have been critically im-
portant in identifying imprinted loci (14), studies often find
only weak correlations between DMRs near gene promot-
ers and differential gene expression (11,12,15). One draw-
back of DMR methods is that they rely on a set of arbi-
trarily defined thresholds for the size and number of CpGs
to include in the DMR. It is often recommended to adjust
these parameters for each individual dataset since the choice
of these parameters has substantial implications in the num-
bers of DMRs identified and putatively associated genes.
One possible reason DMR methods fail to find a strong
association between differential methylation and expression
is they reduce DNA methylation to a single differential
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value removed from its local context. Recent work, however,
has indicated that a large number of methylation patterns
associate with differential gene expression (16). For exam-
ple, methylation at CpG island-shores, regions of decreased
CpG density flanking CpG islands, correlate with differ-
ential gene expression in colon cancer (17). Further, long
hypomethylated domains in cancer often contain down-
regulated genes (17). Positive correlations between gene
body methylation and gene expression have also been fre-
quently observed (18,19).
Here, we present a new approach to predict gene ex-
pression changes that accounts for all methylation changes
around the TSS. We have previously shown the importance
of capturing methylation changes around the TSS to find
patterns of methylation change that associate with expres-
sion changes using an unsupervised approach (16,20,21).
We now build upon these results to develop a supervised
method called ME-Class (Methylation-based Expression
Classification), which classifies differential expression using
signatures of differential methylation.
We use ME-Class to investigate alternate representations
of DNA methylation and CpG density to identify methy-
lation features that are most important in predicting ex-
pression change using data from theRoadmapEpigenomics
Project. We then use ME-Class to examine the role methy-
lation associated expression changes play in hematopoiesis
using data from the Blueprint Epigenome project. Lastly,
we demonstrate that ME-Class can identify a set of genes
with cancer-specific expression-associated DNA methyla-
tion changes that are silenced in tumor cells, but that are
re-expressed when methylation is removed.
MATERIALS AND METHODS
Roadmap Epigenomics Project (REP) WGBS and mRNA-
seq
Samples from 17 primary tissues with matched whole
genome bisulfite sequencing (WGBS) and RNA-seq were
obtained from the Roadmap Epigenomics Project (REP,
Supplementary Table S1) (22). Fractional methylation (M)
is defined as mCG/CG. Differential methylation (M) is
defined as: M= MS2 − MS1 , where S1 and S2 correspond
to the first and second sample in the differential compar-
ison, respectively. We obtained consolidated methylation
data, which was previously cross-assay standardized and
uniformly processed. All CpG sites were filtered for 4×
coverage or greater and analysis was performed using the
hg19 genome assembly according to analysis standards es-
tablished in REP. We used uniformly processed protein-
coding gene level annotations fromGenecodeV10 to obtain
standardized FPKM values. Each Genecode V10 annota-
tion was converted to RefSeq annotations using the mygene
python package (23). To create a standardized gene set with
high quality methylation data, we excluded genes with am-
biguous or incomplete TSS annotations, genes shorter than
5 kb, genes with <40 CpGs assayed within ±5 kb of the
TSS, genes where all CpGs within ±5 kb of the TSS had
<0.2 methylation change, and alternative promoters. These
filters were used to exclude non-coding and pseudogenes,
genes shorter than the interpolation boundary, genes with
low numbers of CpGs to reduce bias caused by individual
CpGs, and genes with no methylation changes near their
promoter, respectively. We only included RefSeq genes with
cdsStartStat (n= 47 637 genes) and cdsEndStat (n= 47 621
genes) with ‘cmpl’ according to the UCSC Table Browser.
To eliminate redundant annotations, for any RefSeq genes
with multiple RefSeq IDs corresponding to the same TSS
location, we only used a single RefSeq ID with the lowest
accession number. In analyses with the ROI classifier (see
below), all genes with less than four exons were removed
from analysis. Differentially expressed genes were defined as
genes with ≥2-fold difference between samples after an ap-
plied floor of five FPKM to provide a conservative estimate
of expression change. These filtering criteria have minimal
effect on the fraction of CpG Island (CGI) -associated pro-
moters, which went from 65.9% of genes before filtering to
67.3% after. CpG Islands were defined based on the CGI
track from the UCSC Genome Browser (24). A full sum-
mary of filtered gene counts is in Supplementary Table S2.
Blueprint Epigenome project WGBS and mRNA-seq
WGBS and RNA-seq from 32 venous and cord blood sam-
ples were obtained from the Blueprint Epigenome project
(25). Genome coordinates from hg38 were converted to
hg19 using liftOver (24). All other analysis steps were per-
formed identically to the REP data above.
Cancer WGBS and mRNA-seq
Breast invasive carcinoma (BRCA), colon adenocarcinoma
(COAD), rectum adenocarcinoma (READ) and uterine
corpus endometrial carcinoma (UCEC) matched normal-
tumor WGBS and mRNA-seq samples were obtained from
The Cancer Genome Atlas (TCGA) to train a model of
tumorigenesis. Normal sigmoid colon (E106) WGBS and
mRNA-seq data were obtained from REP (22). HCT116
DKO1 (bi-allelic knockout of DNMT1 and DNMT3b)
WGBS and mRNA-seq data were obtained from Blattler
et al. (26). All other analysis steps were performed identi-
cally to the REP data above.
Single window (SW)
We computed the average methylation across a single, fixed
±1 kb window around the TSS of each gene (17,27). We
performed logistic regression to predict differential expres-
sion from the average methylation change around the TSS
(Figure 1A and B). Logistic regression cross-validation was
run with 1000 maximum iterations of the optimization al-
gorithm.
Differentially methylated regions (DMRs)
We used DSS-single to compare DMRs between individual
samples (28).We identifiedDMRs (P< 0.01) and used their
size (bp), average differential methylation, and stranded dis-
tance (bp) to the closest TSS (0 if overlapping by ≥1 bp)
as features for gene expression change classification with a
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Figure 1. Models of DNA methylation and validation framework for pre-
dicting differential gene expression change from differential DNA methy-
lation. (A) Heat map indicates methylation status at individual CpG
sites––red is fully methylated, blue is fully unmethylated––for an example
gene in two samples (Methyl. 1 and Methyl. 2). Individual points below
indicate differential DNA methylation (Methyl. 2––Methyl. 1) across the
example gene at individual CpG sites. (B) Example regions that would be
used to calculate the single window (SW) and differentially methylated re-
gion (DMR) using the data in (A). (C) Regions used to calculate methy-
lation features for the Region of Interest (ROI) representation of the gene
in (A). (D) ME-Class representation of the gene in (A). Each individual
point is the differential methylation value used as a feature in a Random
Forest after interpolation and smoothing. (E) Cross-validation compari-
son framework. Evaluation is performed sample-wise across the 17 sample
comparisons. In the evaluation comparison, genes are split into 10-folds.
Prior to training, each evaluation gene is removed for all other tissues. Fur-
ther model details are in Table 1. CGI = CpG island.
Regions of interest (ROI)
The Regions of Interest (ROI) classifier reduces DNA
methylation to multiple averaged values across annotated
gene elements (upstream, exon, intron and downstream
bins) as features for a Random Forest (RF) to predict ex-
pression class (Figure 1C). ROI classifier features were im-
plemented as described in (29) to predict differential expres-
sion class rather than single sample binned expression val-
ues. We used a RF classifier with 100 trees as originally de-
scribed. Increasing the number of trees to 1001 increased
run time substantially without an appreciable increase in
performance (Supplementary Figure S1).
ME-Class
Gene signatures were constructed as in VanderKraats et al.
with minor modification (16). This signature allows the
model to incorporate the entire profile of methylation
changes across the gene’s promoter region including any
CGI and CGI-shore regions (Figure 1A and D). In addi-
tion, these signatures allow comparison of methylation dif-
ferences between genes, which have CpGs in different loca-
tions. We applied a localized z-score normalization of each
differential methylation value in a 10 kb window surround-
ing the TSS based upon the distribution of methylation val-
ues in a 100 kb surrounding anchor window. We created
methylation signatures using a piecewise cubic hermite in-
terpolating polynomial (PCHIP) to interpolate a curve of
z-score normalized differential methylation values in the
10 kb window around the TSS for each differentially ex-
pressed gene. The interpolated curve was then subjected to
Gaussian smoothing with a bandwidth of 50 bp. Since CpG
methylation values are highly autocorrelated (30), interpo-
lation and smoothing of the data decrease the influence of
sequencing error at individual CpGs (16). Similar smooth-
ing approaches have shown a marked improvement in the
ability to determineDMRs (31). To obtain discrete features,
we subsampled our interpolatedmethylation signature at 20
bp resolution. We then used these features with a RF classi-
fier with 1001 estimators. We initially chose a RF classifier
since it provides a nonparametric model, has a low number
of hyperparameters, generates an internal unbiased estimate
of testing error, identifies feature importance, and typically
performs near-optimally with minimal tuning (32). Logistic
Regression (LR) (max iter= 1001), Gradient BoostedClas-
sification Trees (GBCT) (n estimators = 1001), Gaussian
Naı¨ve Bayes (NB), L2 distance-based k-Nearest Neighbors
(kNN) (k= 21), and Dynamic TimeWarping (DTW) kNN
(k = 21) were implemented with default parameters other
than stated modifications. All machine learning methods
were implemented with scikit-learn and mlpy (DTW only)
python packages (33,34).
Whole gene methylation models
We also implemented three alternative representations of
methylation data to incorporate the full profile of methy-
lation changes across the entire gene (Supplementary Fig-
ure S2A): Whole Scaled Gene (WSG), Whole Gene (WG),
and Uniform Gene Features (UGF). For each representa-
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TSS and downstream of the TES (Transcription End Site)
(20 bp resolution). These regions/features were then added
to specific features for each representation as follows. The
WSG representation is an emerging representation in the lit-
erature to describe methylation changes by linearly scaling
the methylation profile across the entire gene (22,26,35). To
obtain discrete features, we used 500 bins across the gene
(Supplementary Figure S2B). For the WG representation,
we modeled methylation data as a curve (subsampled to 20
bp resolution) across the entire length of the gene (Supple-
mentary Figure S2C). For the UGF approach, we repre-
sented each exon with 10 scaled bins and each intron with
30 scaled bins. Multiple exons or introns were not averaged
together (Supplementary Figure S2D). For WSG, we used
a RF classifier. For both WG and UGF, we used curve sim-
ilarity as defined with DTW (36), and classified expression
changes using kNN (k = 21).
Classifier performance
To evaluate the amount of data needed to train ME-Class,
we divided the 17 REP datasets into eight samples that were
held out for evaluation and nine samples that were used for
training. For a given number of training samples (n), nine
random permutations of n pairwise comparisons were cho-
sen from the training samples and used to train nine ME-
Class classifiers. The resulting nine classifierswere then eval-
uated on a fixed set of eight comparisons from the holdout
evaluation samples (Supplementary Figure S10).
To evaluate each classifier, we implemented a conserva-
tive two-stage cross-validation framework (Figure 1E) to
ensure that the model does not overfit to any given sample
or individual gene. For a given evaluation, we performed
the following procedure: (i) leave-one-out sample pair cross
validation: We divided all differential training samples into
a training set and an evaluation set. This ensured that no
individual sample from the training set appears in the eval-
uation set; (ii) 10-fold gene cross validation: we randomly
divided the genes from the evaluation sample into 10-folds.
To evaluate each fold, we first removed examples of all genes
in the evaluation fold from all samples in the training set
prior to training. Thus, if gene A is in the evaluation data,
no examples of gene A for any tissue are used for training.
We then trained on the training samples/genes and eval-
uated the chosen fold of genes in the evaluation samples.
We then repeated this process 10 times for each fold of the
evaluation sample and for each differential sample in the
dataset. This process helped the classifier generalize across
genes and samples by ensuring that each evaluation gene
does not observe either an example of itself or any other
genes from its individual sample.
Average performance based on the accuracy, reject rate,
positive predictive value (PPV), and negative predictive
value (NPV) was reported across all genes treated as a sin-
gle pool from all samples. Testing accuracy was defined as
the number of genes with correctly predicted expression di-
vided by total genes returned. Receiver Operator Charac-
teristic (ROC) and Precision Recall (PR) curves were aver-
aged to provide a sample-wise level of reporting. RF fea-
ture importance was estimated as Gini importance. Unless
otherwise stated, all statistical comparisons were performed
using FDR-corrected paired, pairwise Wilcoxon rank sum
test in R.
Gene ontology analysis
Gene Ontology analysis was performed by analyzing gene
lists with Functional Annotation Clustering with default
parameters from DAVID (37). Blueprint analysis gene lists
were identified by any genes with ≥90% probability of clas-
sification in≥2 differential samples. Colon cancer gene lists
were identified by any down-regulated genes with a ≥90%
probability of classification by ME-Class (see discussion of
reject rate in Results).
RESULTS
ME-Class predicts gene expression change from differential
methylation in tissue samples
Since the goal of most genome-wide methylation studies is
to identify how changes in methylation alter expression, we
examined the ability of methylation to predict differential
expression change. We first sought to understand whether a
methylation signature approach (i.e. modeling the entirety
of methylation changes around a gene’s TSS) could outper-
form current DMR, single window (SW), and ROI meth-
ods in finding genes with associated differential methyla-
tion and expression (Figure 1, Table 1). To compare su-
pervised classifiers, we used WGBS DNA methylation and
RNA-seq data from the Roadmap Epigenomics Project for
17 tissue samples (Supplementary Table S1) (22). We imple-
mented a conservative sample-wise and 10-fold gene-wise
cross-validation framework that ensures the genes in the
evaluation step have not been seen in any tissue during train-
ing (Figure 1E). Since patterns of differential DNA methy-
lation can be very similar between datasets, this evaluation
framework tests the strength of theDNAmethylation repre-
sentation and the universality ofDNAmethylation patterns
rather than the ability to simply recall an observed gene’s
methylation signature.
Using this framework,ME-Class outperformed all meth-
ods by receiver operator characteristic (ROC) curve analy-
sis (P< 10−3 forME-Class compared to each of DMR, SW
and ROI, Figure 2A) and precision-recall (PR) analysis (P
< 10−3 for ME-Class compared to each of DMR, SW and
ROI, Supplementary Figure S3C). In addition, ME-Class
performed better than or equal to each of the other meth-
ods analyzed for any individual comparison based on ROC
AUC (area under the curve; Figure 2C). Interestingly, there
was a large variability in the classification performance of
the differential samples. While in the case of keratinocyte
comparisons this could likely be explained by poor sequenc-
ing coverage (Figure 2E and F), this per-sample perfor-
mance difference appeared primarily to be due to funda-
mental differences in the methylation profiles of the expres-
sion classes. The ROC AUC was strongly correlated (Fig-
ure 2D, R2 = 0.87) with the average methylation difference
between up- and down-regulated genes in the region +0.5
kb to +2.5 kb relative to the TSS (the most important re-
gion for classification, Figure 2B).While we cannot rule out
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Table 1. DNA methylation features and classification methods for each model in Figure 1
DNA methylation representation Features Gene expression change classification method
Single Window (SW) mCG/CG ±1 kb of TSS Logistic regression (LR)
Differentially Methylated Regions (DMR) Distance from TSS to DMR (bp) Random forest (RF)
DMR width (bp)
Avg. mCG/CG
Regions of Interest (ROI) Avg. mCG/CG: Random forest (RF)







Five 400 bp bins 3′ of txEnd
Methylation-based Expression Classification
(ME-Class)
mCG/CG of 500 bins (20 bp) ±5 kb of TSS Random forest (RF)
Figure 2. ME-Class outperforms standard methods for tissue-specific ex-
pression classification. Methods were evaluated using 17 tissue samples
from the REPwith the two-stage cross-validation framework in Figure 1E.
(A) ROC analysis from a combination of all 17 samples (ROC AUC: ME-
Class, 0.76; ROI, 0.71; DMR, 0.63; SW, 0.66). (B) RF feature importance
from ME-Class trained on all 17 differential comparisons from REP. (C)
ROCAUC for each of the 17 samples comparisons. (D) Mean z-score nor-
malized methylation difference of the region [+0.5 kb, +2.5 kb] relative
to the TSS. (E) Average CpG coverage and (F) average fraction of CpGs
within the 10 kb window around the TSS for each REP sample. S1 and
S2 correspond to the first and second sample in the evaluation differential
comparison. L. Ventr. = Left ventricle, Hippo. = Hippocampus, R. Ventr.
= Right ventricle, Esoph. = Esophagus, R. Atrium = Right Atrium, Ker-
atin. = Keratinocyte, Intest. = Intestine.
Figure 3. ME-Class identifies more genes at higher accuracy with
expression-associated methylation changes in tissue-specific differential
comparisons in the REP dataset. (A) Classifier accuracy versus 1––reject
rate. (B) Accuracy of testing sample at 90% operating probability of classi-
fication. (C) Number of genes identified with expression-associatedmethy-
lation changes at 90% operating probability of classification. Points in (B)
and (C) indicate the performance of individual REP sample comparisons.
** indicates P< 0.005 and *** indicates P< 0.001. All other comparisons
were not significant for  = 0.05.
correlation, it appears that most normal tissue methylation-
based expression classification derives fromTSS 3′ proximal
methylation changes.
ME-Class generates a list of genes with associated differen-
tial methylation and expression
Transcription can be influenced by multiple factors other
than DNA methylation, such as transcription factors or
chromatin modifications. Thus, the key issue is whether
ME-Class can be used to identify a subset of genes that have
high quality associations between differential methylation
and expression. For this purpose, we introduced a reject rate
into the classifier that allows us to control for external fac-
tors other than methylation that indicate gene expression.
The reject rate excluded genes that cannot be reliably pre-
dicted (i.e. they likely do not have methylation-associated
expression changes) using a threshold for the probability of
classification output by each classifier. In practical terms,
the reject rate allows one to set a parameter based on the
cross-validation evaluation error that can control the false
positive rate when runningME-Class on unseen samples. In
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SW and DMR methods in accuracy and proportion of the
genes returned across all rejection rates.
We next set the classification probability at 90% and ex-
amined howmany genes were returned by each method and
the accuracy of this list. ME-Class returned significantly
more genes than the SW and ROI methods (ROI: P = 2.9
× 10−3; SW: P = 9.2 × 10−4) and was significantly more
accurate at 90% probability of classification than the DMR
method (DMR: P = 3.0 × 10−3) (Figure 3B and C). ME-
Class returned the largest average number of genes, 217,
at the highest level of accuracy (93.1%). The ROI and SW
methods achieved lower levels of accuracy and returned
a much lower average number of genes (ROI: 81 genes,
86.9% accuracy; SW: 66 genes, 84.5% accuracy). The DMR
method returned a similar average number of genes, 207, but
at the cost of a much lower level of accuracy (83.3%). This
implies that the nearest isolated DMR is often insufficient
to predict the expression class even when tuning the DMR
parameters to find optimal segmentation parameters.
At 90% probability of classification, ME-Class did not
show any bias towards the positive (up-regulated) or nega-
tive (down-regulated) class (Supplementary Figure S3A and
B). ME-Class matched or exceeded the accuracy given the
probability of classification, indicating that this probability
can be used as an estimate of the final classification error
in cross-sample comparisons (Supplementary Figure S3D).
This demonstrates that when running ME-Class on new
samples, the probability of classification can be used as an
estimate of the false discovery rate. Meanwhile, the ROI,
SW and DMR approaches all have a lower accuracy than
the probability of classification at high probabilities indi-
cating that they are likely overfit and do not generalize well
to other datasets.
To understand the difference in whyME-Class was highly
predictive of some genes and not others, we examinedmeta-
gene plots of the methylation signal at predicted genes sub-
set by the probability of prediction. We observed that the
highest predicted genes have the greatest methylation dif-
ference between downregulated and upregulated genes in a
[+0.5 kb, +2.5 kb] region around the TSS of each gene, and
that this signal decays with decreasing probability (Supple-
mentary Figure S4). This dampening of themethylation sig-
nal can likely be attributed to either noise from the WGBS
assay or biological noise from cell-type heterogeneity.
3′ proximal and TSS regions are most predictive of differen-
tial expression
We next sought to understand why ME-Class performed
better by examining which features are most important for
classification. We first developed a series of ME-Class clas-
sifiers each using signatures from 5 kb windows centered
at varying distances away from the TSS (Figure 4A and B).
Performance peaks for a window centered 2 kb downstream
of the TSS, indicating that the most important features exist
downstream of the TSS. There was no substantial difference
observed in ROC AUC between the entire 10 kb window
compared for the 2 kb downstream centered 5 kb window
(Figure 4B). This agrees with our analysis of RF feature im-
portance, which showed that the most important features
Figure 4. Importance of DNA methylation changes 3′ proximal to TSS
for tissue-specific expression classification. Methods were evaluated using
17 REP tissue samples with the two-stage cross-validation framework in
Figure 1E. (A) ROC AUC and (B) 1-reject rate for ME-Class methylation
signatures created from fixed 5 kb windows centered at varying distances
to the TSS. (C) ROC AUC and (D) 1-reject rate for ME-Class methylation
signatures created using increasing window widths centered at the TSS.
Individual points are the performance of individual REP sample compar-
isons.
for gene expression classification occur downstream +0.5 to
+2.5 kb of the TSS (Figure 2B).
We next evaluated the use of aMost Important (MI) win-
dow within the [+0.5 kb, +2.5 kb] region around the TSS
of each gene in the REP dataset (Supplementary Figure
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ME-Class classifier using only features from this region per-
formed substantially worse thanME-Class given data from
the full [–5 kb, +5 kb] region (Supplementary Figure S5),
underscoring the importance of using all the data around
the TSS to represent DNA methylation.
We then designed a series of ME-Class classifiers to ex-
amine how the size of the TSS-centered window affects per-
formance. Increasing the window size beyond 10 kb did not
show substantial improvements in ROC AUC (Figure 4C).
However, after the window size increases greater than 10 kb
there is a decrease in the number of genes returned at 90%
probability of classification (P = 4.5 × 10−3) (Figure 4D).
Combined, these results indicate that high-resolution fea-
tures across a window of at least 5 kb wide and shifted 3′
proximal of the TSS is sufficient to capture the complexity
of methylation signal around the promoter required for ex-
pression prediction in the REP samples.
Alternative models and features to improve ME-Class
We next sought to determine whether the underlying model
used in ME-Class was sufficient for predicting expression.
We were inspired from our previous unsupervised analysis
(16) to design ME-Class to model the changes in methyla-
tion levels around the TSS. However, other features, includ-
ing CpG density, the density of methylated CpG sites, and
gene body methylation, have been described in the litera-
ture to have correlations with expression. Thus, we sought
to understandwhether adding these features would improve
classification performance.
CpG density does not improveME-Class but CpG-poor genes
are more predictive
The density of methylated CpGs has been implied as the
important feature for why CGI methylation affects gene si-
lencing (38,39). We thus compared gene signatures com-
puted from the normalized methylation density (mCG/bp),
CpG density or fractional methylation (mCG/CG) to see
which feature performed best. ROC and PR analysis, as
well as examining the relationship between accuracy and
reject rate, show no substantial increased effect of using
mCG/CG rather than mCG/bp. Unsurprisingly, a model
based on CpG density alone performs nearly equivalent to
random guessing (Supplementary Figure S6a). While the
direct addition of CpG density did not improve perfor-
mance, we found that ME-Class performed worse on CGI-
associated andCpG-rich promoters (SupplementaryFigure
S7). This is in agreement with prior findings that there is
a stronger correlation between methylation and expression
for genes which had no CpG island as compared to those
with CpG Islands (40). However, since more genes contain
CGIs, ME-Class identifies a strong association (90% prob-
ability of prediction) between differential methylation and
expression for more CGI-associated genes (mean = 135 for
REP samples) than CGI-poor genes (mean = 108). A sim-
ilar trend is observed for CpG-rich (mean = 170) versus
CpG-poor (mean = 73) promoters. Previously, it has been
hypothesized that CGI-associated and CpG-rich genes tend
to remain unmethylated in normal cell-types irrespective of
their expression levels (41); however, our analysis suggests
that while there are better associations between methyla-
tion and expression for non-CGI-associated genes, there are
more CGI-associated genes that show strong associations.
The addition of gene body methylation changes does not im-
prove ME-Class
Since gene body methylation has been shown to be pos-
itively correlated with gene expression (18,19,40), we ex-
amined if we could improve ME-Class by adding addi-
tional gene features that modeled methylation changes in
the gene body.ME-Class performancewas not substantially
improved by adding features for averaged gene features sim-
ilar to that of the ROI method such as the average methy-
lation of internal exons, introns, and region downstream of
the gene (Supplementary Figure S6B). This was unsurpris-
ing, since feature importance analysis of the ROI classifier
indicated that the most important features for classification
were the methylation levels of the first exon and first intron,
which substantially overlap the region from the TSS to +5
kb.
We also investigated whether other gene representations
could determine whether methylation information from the
gene body could improve classification performance. There-
fore, we implemented three alternative approaches to model
DNA methylation throughout a gene: Whole Scaled Gene
(WSG), Whole Gene (WG), and Uniform Gene Features
(UGF) (Supplementary Figure S2B–D). In the WSG ap-
proach, themethylation profile is interpolated across the en-
tire gene and then all genes are rescaled to a uniform length.
This is a common method to visualize genomic trends in
genome-wide methylation data (22,26,35). WG is similar,
but the genes are not scaled after interpolation. Lastly, in
the UGF approach methylation is interpolated then methy-
lation features are extracted using a uniform number of bins
for each exon and intron. All alternative approaches include
regions –5 kb of the TSS and +5 kb of the TES. Using ROC
AUC analysis, the TSS-centric (default ME-Class represen-
tation) model outperforms the WG (P = 3.7 × 10−5) and
UGF (P = 2.3 × 10−5) approaches (Supplementary Figure
S2E–G). Further, the TSS-centric approach identifies more
genes on average (TSS: 178, WSG: 112) at a higher average
level of accuracy (TSS: 93%,WSG: 89%) than theWSG ap-
proach.
All combined, these results suggest that models that in-
corporate gene body methylation, whether through aver-
age features or whole gene representations, do not substan-
tially outperformmodels comprising only information from
around the TSS.Our results demonstrate that features in the
gene body and downstream of the TES are minimally im-
portant when using differential methylation to classify ex-
pression change. Thus, even though there are correlations
between differential gene body methylation and differential
expression, there is minimal new information in the gene
body relative to the information already found in the ±5 kb
region around the TSS.
Optimizing ME-Class
Before using ME-Class to analyze additional samples, we
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formance. Using the REP dataset, we compared the perfor-
mance of the RF, Logistic Regression, Gradient Boosted
Classification Trees (GBCT), Naı¨ve Bayes, and k-NN. We
also compared the RF-based approach to a method us-
ing DTW as a curve similarity metric for kNN classifica-
tion. RF, Logistic Regression and GBCT outperformed the
remaining machine learning methods by both ROC AUC
analysis and examining the relationship between accuracy
and reject rate (Supplementary Figure S8). We also found
that ME-Class performed similarly well as long as smooth-
ing parameters were maintained below 200 bp (Supplemen-
tary Figure S9A and B). Interpolation and smoothing serve
to decrease inaccuracy of low coverage methylation calls, as
has been observed in DMR callers (31). Changes in the in-
terpolationmethod also had no substantial effect on perfor-
mance (Supplementary Figure S9C). To assess how much
training data ME-Class requires for accurate classification,
we separated the REP dataset into nine differential sam-
ples for training held out 8 differential samples for evalua-
tion (see details in Materials and Methods). ME-Class was
consistent within 0.02 ROC AUC of the full training set af-
ter using three samples (Supplementary Figure S10A) and
showed minimal increases in obtaining consistent gene sets
as the full training set when using more than five samples
(Supplementary Figure S10B) or 20 000 genes (Supplemen-
tary Figure S10C).
Myeloid/Lymphoid differential methylation comparisons are
most predictive of expression change
We next applied ME-Class to identify methylation-
associated expression changes in hematopoiesis. We used
WGBS and mRNA-seq datasets provided by the Blueprint
Epigenome project in cord and venous blood composed of
32 isolated samples from 10 cell types. We retrained ME-
Class using the entire 17 samples from the REP data above
and then used this model to find methylation-associated
expression changes in 469 hematopoietic lineage-wise
differential comparisons. We found a large variation in
the number of genes identified based on the cell-types
being compared. Comparison of relatively distantly related
lymphoid and myeloid lineages resulted in 54–218 genes
(mean = 88) returned at 90% probability of classification
(Figure 5A and B). Gene ontology analysis suggests that
genes identified in myeloid-lymphoid comparisons are
enriched for genes involved in T-cell activation, leukocyte
differentiation and hematopoiesis. Similar performance
results were found if we characterize the classifier based on
ROC AUC (Figure 5B). This contrasts with a comparison
of closely related myeloid cells such as macrophages,
monocytes and dendritic cells, which identified between 0
and 55 genes when comparing any two cell types (mean =
16 genes; P = 2 × 10−16) and demonstrate performance
near random guessing (ROC AUC = 0.55 ± 0.04). Neu-
trophil samples stood out as particularly poor performers
in all comparisons suggesting that either there are not
methylation-associated expression differences in these cells,
or that methylation profiles in these cells are fundamentally
different from that of other tissues (Supplementary Figure
S11).
Based on ROC analysis there was an inverse relation-
ship between the relatedness of the cells being compared
and the ROC AUC fromME-Class (Figure 5C). Similar re-
sults were also obtained using anME-class model trained a
combination of closely- and distantly-related hematopoietic
cell types (Supplementary Figure S12). While other analy-
ses have examined associations upon myeloid (42) and B-
cell differentiation (43), this analysis demonstrates that truly
predictive differences in differential DNA methylation pri-
marily reside between the myeloid and lymphoid lineages,
the two major lineages derived from hematopoietic stem
cells.
ME-Class identifies subsets of genes sensitive to demethyla-
tion in colon cancer
We next examined whether ME-Class can accurately iden-
tify genes that are hypermethylated and silenced in a model
of colon cancer. For this problem, we first trained a cancer-
specificME-Classmodel usingWGBS andmRNA-seq data
from four different normal-tumor differential comparisons
from The Cancer Genome Atlas (TCGA) (BRCA, COAD,
READ and UCEC). We then used this cancer-specific ME-
Class model to identify methylation-associated changes in
expression in a colon cancer cell line (HCT116) relative to
normal colon tissue (Figure 6A). We observed that the pri-
mary peak of feature importance in our trainedmodel shifts
from the region [+0.5 kb, +2.5 kb] downstream of the TSS
in the REP tissue-specific model to the region [–0.5 kb, +1.5
kb] overlapping the TSS in the TCGAnormal-tumormodel
(Figure 6B). We found a severe class imbalance; 187 genes
with methylation-associated expression changes were iden-
tified as down-regulated, but no genes were predicted as
up-regulated. Functional annotation clustering of gene on-
tology of the 187 down-regulated, identified genes showed
that these genes are enriched for C2H2 zinc fingers, previ-
ously shown to be hypermethylated and silenced in carcino-
genesis, and are involved in cell adhesion, whose dysregu-
lation is important for tumorigenesis (44). To understand
whether the tumor-associated hypermethylation was func-
tional, we examined what happened to these genes after re-
moval of methylation by double knockout of DNMT1 and
3b (HCT116 DKO1). Genes with an ME-Class signature
showed a significant upregulation of expression relative to
down-regulated genes not identified by ME-Class (Figure
6C, P = 1 × 10−14). Our analysis from this model of colon
cancer demonstrates thatME-Class can identify genes likely
regulated by DNA methylation in human disease and is
consistent with the hypothesis that hypermethylation near
the TSS plays a primary role in modulating gene activity
cancer (41,45,46).
DISCUSSION
One challenge in the field of DNAmethylation analysis has
been the difficulty of integrative analysis of genome-wide
DNA methylation and expression data. While methods ex-
ist to facilitate this task, they have many parameters that
must be set, often with no clear way to make intelligent
choices for their values. For example, DMR and SW ap-
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Figure 5. ME-Class performance is higher for cell comparisons between distally related cell lineages as opposed to directly related ones. (A) Accuracy versus
1-reject rate and (B) ROC of selected cell-types (ROC AUC: Lymphoid versus Myeloid, 0.72 ± 0.02; Megak. versus other Myeloid, 0.68 ± 0.02; Erythrob.
versus Other Myeloid, 0.68 ± 0.02; CD4+ versus CD8+ T cells, 0.66 ± 0.02; Other Myeloid, 0.55 ± 0.03). (C) ME-Class ROC AUC performance for each
sample-wise comparison of hematopoiesis samples. Vb = venous blood, cb = cord blood, Erythrob. = Erythroblast, Alt Act Macrophage = Alternating
activated Macrophage, Inflam Macrophage = Inflammatory Macrophage, Mat Neutrophil = Mature Neutrophil, Megak. = Megakaryocyte. ROC AUC
error is the standard deviation.
Figure 6. ME-Class identifies genes re-expressed after removal of DNA
methylation in a model of colon cancer. (A) Experimental scheme. We first
built an ME-class model using WGBS data from four tumor-normal pairs
from TCGA. We then used this model to identify genes with expression-
associated methylation changes upon tumorigenesis (HCT116) from nor-
mal colon (REP) and evaluate the demethylation effect by genetic manipu-
lation (DKO1: bi-allelic knockout of DNMT1 andDNMT3b inHCT116).
(B) Feature importance for the ME-Class training model built from four
TCGA tumor-normal samples (COAD, BRCA, READ, UCEC). C) Vio-
lin plots showing the expression fold change in HCT116 DKO1 cells using
down regulated differentially expressed gene sets identified with (n = 187
genes) and without (n = 5370 genes) identified methylation signatures.
as minimum window size or a minimum number of CpGs)
that can drastically change the list of genes with predicted
methylation changes. Our results from REP analysis show
that these methods cannot be used to accurately predict ex-
pression fromDNAmethylation, likely because they cannot
model the signal complexity necessary to associate methy-
lation and expression change (Figure 2). Incorporating the
complexity of patterns, rather than reducing methylation to
a single or even multiple averaged values, is critical for the
success of ME-Class. Alternative gene representations that
incorporate gene body methylation perform no better than
representations that focus on the region around a gene’s
TSS (Supplementary Figure S6B). Thus, the information
obtained from correlations between gene body methylation
and expression is either too noisy, or it is redundant with
information within ±5 kb of the TSS. In the future, it may
be possible to improveME-Class by adding features specific
to enhancers, but first we need better computational tools
and experimental data across multiple cell types to connect
regulatory units with specific genes.
In this study, we asked whether we could build models
of DNA methylation that would generalize across different
genes and across samples. For this purpose, we established a
strict evaluation framework to test changes in methylation
to identify these most likely affected genes. Using a training
and evaluation paradigm that consists of both cross-sample
and cross-gene evaluation, we have shown that ME-Class
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performs well across high quality datasets without the need
for tuning for individual datasets. However, there are lim-
its to this generalization. For example, tissue-specific and
cancer-specific datasets require different models to achieve
high performance. Further, even though we excluded alter-
native promoters from this analysis to compare methods
across a set of high quality reference genes, ME-Class can
use isoform-specific promoter locations and expression data
as input to provide an isoform-level analysis.
The role of gene-specific DNA methylation changes in
development has been debated for many years (47). If pro-
moter DNA methylation played a primary role in regulat-
ing cell-type specific expression changes then one would ex-
pect to observe a large fraction of differentially expressed
genes with methylation-associated expression changes even
among closely related cell types. However, we do not ob-
serve this. On the other hand, if methylation were a con-
sequence of expression change, then one would expect to
see a large number of methylation-associated expression
differences in distantly related cell types or tissues, but
not in closely related ones. Our results from ME-class are
consistent with the latter statement. ME-Class identifies
on average 7.5% (217 genes/sample) of differentially ex-
pressed genes from different tissues in REP are associated
with promoter-proximal methylation changes at 90% accu-
racy, and 2.5% (88 genes/sample) of differentially expressed
genes for distantly related hematopoietic lineages (myeloid
versus lymphoid). However, ME-class performs poorly on
sample comparisons of closely related hematopoietic lin-
eages, often identifying few genes (myeloid versus myeloid;
mean = 0.6% or 16 genes/sample). Our data is thus con-
sistent with a model where transcriptional changes pre-
cede promoter-proximal methylation changes during dif-
ferentiation, and thus, these tissue- and cell- specific DNA
methylation changes are likely a consequence of transcrip-
tional changes. While DNA methylation is unlikely to ini-
tiate tissue-specific expression, we cannot rule out the pos-
sibility that these promoter-proximal methylation changes
play a later role in maintaining these transcriptional pro-
grams.
In contrast, the reactivation of genes identified by ME-
Class as methylated and silenced upon removal of DNA
methylation is consistent with the hypothesis that methy-
lation changes at the promoter in cancer play a direct role
in gene regulation. This observation is consistent with our
recent work showing that an unsupervised analysis of dif-
ferential methylation data in AML could identify a set of
genes that were likely to be up-regulated upon treatment
with demethylating agents (21). We also observe a shift
in the most informative region for expression associated
methylation changes from [+0.5 kb, +2.5 kb] in a tissue-
specific model to [–0.5 kb, +1.5 kb] in a cancer-specific
model.While early studies suggested that tissue-specific and
cancer-specific expression-associated methylation changes
were similar, our results are in agreement with more re-
cent studies that use higher resolution methods and larger
numbers of samples (12,40,48,49). Further, the observation
that both windows are shifted downstream of the TSS is in
agreement with recent studies that have suggested that the
transcriptional activator p300 can bind downstream of the
TSS at unmethylated CpG Islands to increase gene expres-
sion (40), and that decreases in methylation downstream of
the TSS co-occur with increases in active H3K4me3 that
also shift downstream of the TSS (49,50). This difference
in expression-associated methylation changes may explain
why methylation appears to play a role in gene silencing in
cancer, but not in development. In addition, the context de-
pendent nature of these models has a profound effect on
downstream applications indicating that different methyla-
tion models may need to be trained for different contexts
(i.e. cancer-specific models need to be trained to understand
expression-associatedmethylation changes in cancer). Once
these models are trained, they are applicable across other
similar datasets.
As more large-scale, genome-wide DNA methylation
studies of the differences between matched normal and tu-
mor samples become available, tools such as ME-class will
prove invaluable to understand how specific methylation
changes affect transcription. In addition, our results show
that ME-Class is a powerful tool to identify genes that are
silenced by methylation in disease and could be used to fa-
cilitate the identification of patients who may benefit from
clinically-approved demethylating therapeutics (51).
AVAILABILITY
ME-Class is publicly available on Github at http://github.
com/cschlosberg/me-class.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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